eli lilly stock retatrutide shares rise on hopes that next-gen drug will extend lead in weight-loss market Eli Lilly's (LLY) New Drug

There is no established washout protocol for switching between these drugs yet

The real priority should be: Understanding the underlying condition Correcting the root cause Using medication only as supportive intervention when required When used thoughtfully, medical support can be effective

No GLP-1 injections use a very small needle and are designed for easy, at-home use

TODAY.com

Coverage varies by state, with certain states providing coverage options recently

Heres why: Even though injectable GLP-1s still lead on clinical efficacy (15 and 20% weight loss with Wegovy and Zepbound respectively) and dominate the market to date, theres a segment of patients who would prefer an oral option over self-injections